Several factors support the theoretical viability of oral BPC-157, though human outcomes remain unproven: Gastric Stability: BPC-157 was originally studied for gastric protection in animal models, meaning the compound was administered directly into the stomach in research settings
The cell lines were cultured in DMEM medium containing 4.5 g/ml glucose and L-glutamine (Gibco) supplemented with 10% heat-inactivated fetal calf serum (Gibco) and 100 U/ml penicillin and 100 g/ml streptomycin (Gibco)
The two mechanisms complement each other, accelerating healing timelines that would be longer with either peptide alone
Whats more, that three-capsule dose is sufficiently strong that you could choose to take only two of the three capsules and still get significant therapeutic benefits from doses higher than most competitors provide: Even a one-capsule dose offers a larger NAD+ precursor dose and more TMG than similar products from Perpetua.Life, Renue by Science, and others in the NAD+ boosting space
Blood Pressure Effects: Most users experience no cardiovascular side effects
Glutathione is produced in a separate reaction from the methionine cycle, Illustrated inFIG
